Small airway dysfunction as predictor and marker for clinical response to biological therapy in severe eosinophilic asthma: a longitudinal observational study

BACKGROUND: Anti-T2 biological therapies have proven to effectively reduce acute exacerbations and daily doses of oral steroids in severe eosinophilic asthma. Despite the remarkable clinical efficacy, there are usually only moderate improvements in airflow limitation, suggesting that other measures...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Respir Res
Asıl Yazarlar: Abdo, Mustafa, Watz, Henrik, Veith, Vera, Kirsten, Anne-Marie, Biller, Heike, Pedersen, Frauke, von Mutius, Erika, Kopp, Matthias V., Hansen, Gesine, Waschki, Benjamin, Rabe, Klaus F., Trinkmann, Frederik, Bahmer, Thomas
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2020
Konular:
Letter to the Editor
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7579879/
https://ncbi.nlm.nih.gov/pubmed/33087134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-020-01543-5
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller